Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy.
Guckenberger M, Klement RJ, Allgäuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, Ernst I, Ganswindt U, Hass P, Henkenberens C, Holy R, Imhoff D, Kahl HK, Krempien R, Lohaus F, Nestle U, Nevinny-Stickel M, Petersen C, Semrau S, Streblow J, Wendt TG, Wittig A, Flentje M, Sterzing F. Guckenberger M, et al. Among authors: holy r. Radiother Oncol. 2016 Mar;118(3):485-91. doi: 10.1016/j.radonc.2015.09.008. Epub 2015 Sep 15. Radiother Oncol. 2016. PMID: 26385265
Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis.
Guckenberger M, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N. Guckenberger M, et al. Among authors: holy r. J Thorac Oncol. 2013 Aug;8(8):1050-8. doi: 10.1097/JTO.0b013e318293dc45. J Thorac Oncol. 2013. PMID: 23817193 Free article.
Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
Guckenberger M, Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Flentje M. Guckenberger M, et al. Among authors: holy r. Radiother Oncol. 2013 Oct;109(1):13-20. doi: 10.1016/j.radonc.2013.09.005. Epub 2013 Oct 30. Radiother Oncol. 2013. PMID: 24183066
Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Guckenberger M. Klement RJ, et al. Among authors: holy r. Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):732-8. doi: 10.1016/j.ijrobp.2013.11.216. Epub 2014 Jan 7. Int J Radiat Oncol Biol Phys. 2014. PMID: 24411630
Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis.
Schanne DH, Nestle U, Allgäuer M, Andratschke N, Appold S, Dieckmann U, Ernst I, Ganswindt U, Grosu AL, Holy R, Molls M, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Guckenberger M. Schanne DH, et al. Among authors: holy r. Strahlenther Onkol. 2015 Feb;191(2):125-32. doi: 10.1007/s00066-014-0739-5. Epub 2014 Aug 27. Strahlenther Onkol. 2015. PMID: 25159135
Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer.
Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, Sauer O; Deutschen Gesellschaft für Radioonkologie (DEGRO). Guckenberger M, et al. Among authors: holy r. Strahlenther Onkol. 2014 Jan;190(1):26-33. doi: 10.1007/s00066-013-0450-y. Epub 2013 Sep 21. Strahlenther Onkol. 2014. PMID: 24052011 Free PMC article.
76 results